Famotidine and Nosebleed - a phase IV clinical study of FDA data

Summary:

Nosebleed is found among people who take Famotidine, especially for people who are female, 60+ old, have been taking the drug for < 1 month.

The phase IV clinical study analyzes which people take Famotidine and have Nosebleed. It is created by eHealthMe based on reports of 64,982 people who have side effects when taking Famotidine from the FDA, and is updated regularly. You can use the study as a second opinion to make health care decisions.

Phase IV trials are used to detect adverse drug outcomes and monitor drug effectiveness in the real world. With medical big data and AI algorithms, eHealthMe is running millions of phase IV trials and makes the results available to the public. Our original studies have been referenced on 600+ medical publications including The Lancet, Mayo Clinic Proceedings, and Nature.

On Aug, 14, 2023

64,982 people reported to have side effects when taking Famotidine.
Among them, 444 people (0.68%) have Nosebleed.

What is Famotidine?

Famotidine has active ingredients of famotidine. It is often used in gastroesophageal reflux disease. eHealthMe is studying from 66,310 Famotidine users for its effectiveness, alternative drugs and more.

What is Nosebleed?

Nosebleed (bleeding from nose) is found to be associated with 3,547 drugs and 2,989 conditions by eHealthMe.

Number of Famotidine and Nosebleed reports submitted per year:

* Approximation only. Some reports may have incomplete information.

Do you take Famotidine and have Nosebleed?

Check whether Nosebleed is associated with a drug or a condition

How to use the study?

You can discuss the study with your doctor, to ensure that all drug risks and benefits are fully discussed and understood.

Related studies

How severe was Nosebleed and when was it recovered:

Nosebleed in Famotidine

Expand to all the drugs that have ingredients of famotidine:

Nosebleed and drugs with ingredients of famotidine (808 reports)

Alternative drugs to, pros and cons of Famotidine:

Famotidine (66,310 reports)

Common Famotidine side effects:

Chronic kidney disease: 4,731 reports
Diarrhea: 3,954 reports
Fever: 3,602 reports
Fatigue (feeling of tiredness): 3,357 reports
Pneumonia: 3,076 reports
Thrombocytopenia (decrease of platelets in blood): 2,975 reports
Acute kidney failure: 2,854 reports
Headache (pain in head): 2,820 reports
Breathing difficulty: 2,790 reports

Browse all side effects of Famotidine:

a b c d e f g h i j k l m n o p q r s t u v w x y z

Nosebleed treatments and more:

Nosebleed (87,739 reports)

COVID vaccines that are related to Nosebleed:

Common drugs associated with Nosebleed:

All the drugs that are associated with Nosebleed:

Nosebleed (3,547 drugs)

Common conditions associated with Nosebleed:

Atrial fibrillation/flutter: 6,595 reports
Stroke: 4,890 reports
High blood pressure: 3,909 reports
Primary pulmonary hypertension: 3,089 reports
Rheumatoid arthritis: 2,745 reports
Pain: 1,900 reports

All the conditions that are associated with Nosebleed:

Nosebleed (2,989 conditions)

How the study uses the data?

The study uses data from the FDA. It is based on famotidine (the active ingredients of Famotidine) and Famotidine (the brand name). Other drugs that have the same active ingredients (e.g. generic drugs) are not considered. Dosage of drugs is not considered in the study.

Who is eHealthMe?

With medical big data and proven AI algorithms, eHealthMe provides a platform for everyone to run phase IV clinical trials. We study millions of patients and 5,000 more each day. Results of our real-world drug study have been referenced on 600+ medical publications, including The Lancet, Mayo Clinic Proceedings, and Nature. Our analysis results are available to researchers, health care professionals, patients (testimonials), and software developers (open API).

WARNING, DISCLAIMER, USE FOR PUBLICATION

WARNING: Please DO NOT STOP MEDICATIONS without first consulting a physician since doing so could be hazardous to your health.

DISCLAIMER: All material available on eHealthMe.com is for informational purposes only, and is not a substitute for medical advice, diagnosis, or treatment provided by a qualified healthcare provider. All information is observation-only. Our phase IV clinical studies alone cannot establish cause-effect relationship. Different individuals may respond to medication in different ways. Every effort has been made to ensure that all information is accurate, up-to-date, and complete, but no guarantee is made to that effect. The use of the eHealthMe site and its content is at your own risk.

If you use this eHealthMe study on publication, please acknowledge it with a citation: study title, URL, accessed date.